Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: Multicenter study

Journal of Gastroenterology

Volumn 37, Issue 11, 2002, Pages 916-921

  Yoshiba, Makoto ^a   Sekiyama, Kazuhiko ^a   Inoue, Kazuaki ^a   Yamada, Masaya ^a   Kako, Makoto ^b   Nagai, Kozo ^b   Takatori, Masao ^c   Iwabuchi, Shogo ^c   Sumino, Yasukiyo ^d   Tanaka, Katsuaki ^e   Hakozaki, Yukiya ^f   Hasegawa, Kiyoshi ^g   Shibuya, Akitaka ^h  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b TEIKYO UNIVERSITY MIZONOKUCHI HOSPITAL   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOHO UNIVERSITY   (Japan)

^e YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^f Japan Self Defense Force Ctrl Hosp   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Discrimination equation; Fulminant hepatic failure; Prediction

Indexed keywords

BILIRUBIN; CHOLINESTERASE; PROTHROMBIN;

ACCURACY; ARTICLE; CLINICAL FEATURE; COMA; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LABORATORY TEST; LIVER FAILURE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISCRIMINANT ANALYSIS; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS, VIRAL, HUMAN; HUMANS; INFANT; LIVER FAILURE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTHROMBIN TIME; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0036857626     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200154     Document Type: Article

References (22)

1. Takahashi Y, Kumada H, Shimizu M, Tanikawa K, Kumashiro R, Omata M, et al. A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation. Hepatology 1994;19:1065-71.
2. Bernuau J, Rueff B, Benhamou J-P. Fulminant and sub-fulminant liver failure: definitions and causes. Semin Liver Dis 1986;6:97-106.
3. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-5.
4. Gimson AES, O'Grady JG, Ede RJ. Late onset hepatic failure: clinical, serological and histological features. Hepatology 1986; 6:288-94.
5. Sekiyama K, Yoshiba M, Inoue K, Sugata F. Prognostic value of hepatic volumetry in fulminant hepatic failure. Dig Dis Sci 1994; 39:240-4.
6. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990;60:215-22.
7. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown etiology. Lancet 1995;346:1131-2.
8. Trey C, Davidson LS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, editors. Progress in liver disease. New York: Grune and Stratton; 1970. p. 282-98.
9. Christensen E, Bremmelgaard, Bahnsen M, Andreasen PB, Tygstrup N. Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol 1984;19:90-6.
10. Benhamou J, Goudeau A, Poynard T, Dubois F, Lesack G, Yvonnet B, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986;6:648-51.
11. Tygstrup N, Ranek L. Assessment of prognosis of fulminant hepatic failure. Semin Liver Dis 1986;6:129-37.
12. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1986;97:439-45.
13. Harrison PM, O'Grady JG, Keays RT, Alexander GJM, Williams R. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990;301:964-6.
14. Pereira LMMB, Langley PG, Hayllar KM, Tredger KM, Williams R. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic factors. Gut 1992;33:98-102.
15. Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio Hepatology 1996;24:1392-4.
16. Brechot C, Bernuau J, Thiers V, Dubois F, Goudeau A, Rueff B, et al. Multiplication of hepatitis B in fulminant hepatitis B. BMJ 1984;288:270-1.
17. Feinstone SM, Gust ID. Hepatitis A. In: McIntyre N, Benhamou J-P, Bircher J, Rizzeto M, Rodes J, editors. Oxford textbook of clinical hepatology. Oxford: Oxford Medical Publications; 1991. p. 565-70.
18. Inoue K, Yoshiba M, Sekiyama K, Okamoto H, Mayumi M. Clinical and virological differences between fulminant hepatic failure following acute and chronic infection with hepatitis B virus. J Med Virol 1998;55:35-41.
19. Yoshiba M, Dehara K, Inoue K, Okamaoto H, Mayumi M. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan. Hepatology 1994;19:829-35.
20. Inoue K, Yoshiba M, Sekiyama K, Kohara M. Possible association of serum GBV-C RNA level and disease activity in type G fulminant hepatitis. J Hepatol 1999;30:801-6.
21. McIntyre N, Rosalki S. Biochemical investigations in the management of liver disease. In: McIntyre N, Benhamou J, Bircher J, Rizzetto M, Rodes J, editors. Oxford textbook of clinical hepatology, Oxford: Oxford Medical Publications; 1991. p. 293-306.
22. Yoshiba M, Sekiyama K, Inoue K, Fujita R. Interferon and cyclosporin A in the treatment of fulminant viral hepatitis. J Gastroenterol 1995;30:67-73.